chrisvoncsefalvay/vaers-outcomes huggingface dataset:
nausea; started throwing up late last night, starting to feel like he needs to throw up again.; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea) and VOMITING (started throwing up late last night, starting to feel like he needs to throw up again.) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced NAUSEA (nausea) and VOMITING (started throwing up late last night, starting to feel like he needs to throw up again.). On 18-May-2021, NAUSEA (nausea) had resolved. At the time of the report, VOMITING (started throwing up late last night, starting to feel like he needs to throw up again.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Relevant concomitant product usage were not reported by the reporter. No treatment details were added.
The pt states that "my arm began to hurt, then it became red. The next day it was worse. I ran a fever of 101.6. I started swelling and itching. It went down to my elbow. It was still red and swollen".
Developed fever 24 hrs after receiving Hep A vaccine. Bilateral rash on thighs on 5/19/17. Nasal congestion and runny nose developed 5/17/17. Supportive Care offered.
Full body hives and itchy skin.  Added 50 mg Benadryl 3 x/day and Pepcid AC 1 x/day using topical Benadryl lotion on hives until they got too big.  Called doctor on 04/16/2021 and call back on 04/17/2021 appointment set for 04/19/2021.  Prednisone oral is currently being taken.  Skin is still itchy and with hives.
Two weeks after the vaccination, I'm getting weaker and weaker. Have cold symptom like. Went to dinner. After 10 minutes, experience hiccup. My cousin offered me a bottle of water. I open it and drank it. When I'm about to close it my (R) hand drop the bottle cover. Pick it up again and drop it again. Then I fainted, drop on the ground, slurred speech. All left side is numb with tingling sensation. Until now still experiencing numbness and tingling sensation on (L) Hand and (L) foot.
Client received at a hospital a Moderna COVID 19 vaccine 2nd dose on 3/4/2021 in left arm around 1:20 pm. Client stated that around 7:00 pm on 3/4/2021 developed a pruritus, red and weeping rash with exsanguinous drainage. According to Client the reaction is only at the injection site and approximately 75 mm in size, intermittent itchiness, deep muscle pain and depressed area now at site. Per Client, placed a call to PCP's and was instructed to follow up with health agency or CDC. Client reported to have taken Tylenol, Ibuprofen, Benadryl, Hydroxyzine,used Hydrocortisone cream an ice packs and no resolve. Per client will plan to following up with PCP and continue to monitor site.
Initial unsolicited report received from a pharmacist on 20-Oct-2017. This case involves a 80-year-old female patient, who was vaccinated once with 0.5 ml injection of FLUZONE HIGH-DOSE via intramuscular route (batch number, expiry date, dose in series not reported) in left deltoid on 07-Oct-2017. Patient's medical history and concomitant medications were not reported. On an unknown date, following the vaccination, the patient's left deltoid (injection site) had a raised red area and in the center of that area was a knob like raised area. Lab test and corrective treatment was not reported. Patient did not recover from the events. Follow-up report received from a pharmacist on 02-Jan-2018. Batch number of FLUZONE HIGH-DOSE was reported as UI836AA and expiry date was 02-Apr-2018. Patient received first dose of FLUZONE HIGH-DOSE. Patient's medical history included AFib, hypertension and hypercholesterolemia. Concomitant medications included Losartan, Warfarin, Statin and OTC Multivitamins daily. On an unknown date, following the vaccination, the patient had spot on arm had become "puffier" and more "like a blister" for which the patient consulted with PCP and was referred to a dermatologist. The dermatologist burned the area off on 28-Nov-2017. The dermatologist did not do any additional testing on the site and will not have follow-up to the patient unless the lump comes back. At the time of reporting, the area was flat and red after had been scabbed over from being burned off. No other additional laboratory tests were performed. Events outcome for all the events were recovering at the time of reporting. Documents held by sender: none.
None - wrong vaccine was given, patient was to receive a Varicella vaccine but got the Zostavax vaccine.
Left arm has welt and bump (hard to touch) about the diameter of a 'coke can' (2 inches). Welt is red, rash-like and warm to touch. Yesterday, child experienced fever of 101.5 throughout the day. Today he is grumpy and warm to touch. Mother is giving Motrin. Started with sore throat on 03/09. Experienced small asthma attack on 03/08. Symptoms resolved 03/22/2000.
2-24-04: Four month shots led to significant rash. Patient taken to clinic and treated with Benadryl.
Left upper arm sore, muscle aches, difficult to raise arm. Trouble dressing and moving items.
Patient had a gulf ball size rash that was hot to touch. The patient's rash was also "knot like". The patient's doctors has sent over a Medrol Dose pak for control of her symptoms. Patient states that the symptoms appeared shortly after the vaccine. It is at the same site she was administered the vaccine. Patient once had a reaction to the pneumonia shot, and got cellulitis. Before administering the vaccine, I compared the ingredients of both vaccines, which were different. At the point, I felt comfortable administering the shot.
Mother called; states child has fist size area of redness, warm to touch at site of the DTaP on left upper thigh.
2 wks p/flu shot, pt developed GBS; in a 46 day hospitalization, the pt required mechanical ventilation, plasmapheresis, 2 endotracheal tubes, 2 vascular catheters, PEG & dobhoff tube;
Patient experiencing aches and burning sensation in his shoulder joint. Patient does report the vaccine was administered high on the shoulder. Patient intends to visit his doctor for further evaluation.
no ae; RECEIPT OF THREE DOSES OF ZOSTAVAX; This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On an unknown date in January 2015, the patient was vaccinated with first dose of zoster vaccine live (ZOSTAVAX) (strength, dose, frequency, route, lot/ batch number and expiry date were not reported) for prophylaxis. And on an unknown date in March 2015 and in October 2015, the patient was vaccinated with second and third dose of zoster vaccine live (ZOSTAVAX) (strength, dose, frequency, route, lot/ batch number and expiry date were not reported) for prophylaxis from three separate facilities (extra dose administered). No adverse event was reported. No product quality complaint was reported. The outcome of the events was unknown.
Thirty minutes following receipt of ORIMUNE, TRIPEDIA (Connaught) and RECOMBIVAX HB (Merck) vaccines, this child became pale, vomited twice, then experienced "dry heaving." He was then noted to by hypoactive. he was seen by the physician, who sent him to the emergency room. He become unresponsive in the emergency room. After 2.5 hours, he returned to "normal status" and was sent home. Copies of theis report have been forward to Connaught and Merck, manufacturers of the concomitantly administered vaccines.
16APR95 rash, t104, 18APR95 rash inc; 21APR95 febrile sz-EEG done;
Atrial fibrillation; This is a spontaneous report from a contactable consumer (patient). A 58-years-old-male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number ER8733) at single dose via an unknown route in left arm on 27Mar2021 10:00 for Covid-19 immunization. Medical history included hypertension, hairy cell leukemia, and high cholesterol. Patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications the patient received within 2 weeks of vaccination included simvastatin, lisinopril, doxazosin, and acetylsalicylic acid (ASPIRIN 81mg). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient experienced atrial fibrillation on 14Apr2021 23:45 requiring cardioversion. The event was assessed as non-serious. The event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the event was unknown.
The patient received a 0.5 mL 1st booster dose and is not Immunocompromised. No Adverse reaction was reported.
p/vax pt rpt rash on buttock & legs; macular rash; vesicular lesion on feet; no tx given;afeb;no tx given;
Tachycardia, resting HR approximately 112, started at 11am and continued for next 36 hours.
I went to the doctor for a normal heart exam appointment on 01/27/2022, and when the doctor came in to perform an EKG, they discovered my heart had a flutter and was close to atrial fibrillation. They scheduled me for a transesophageal echocardiogram procedure on 01/31/2022 where they put a tube down my esophagus to take a picture of my heart to determine the proper diagnosis, and then performed a cardioversion where they put paddles on my chest and back and shocked my heart into normal rhythm. After the procedures, I was discharged the same day and have been fine since then. The doctor doesn't want to say directly that the vaccine caused the atrial fibrillation, but also mentioned that's the only thing that could have triggered it.
Numbness of tongue and mouth which extended slightly down my throat, and I had some chest tightness
Pt received J+J as their first vaccine and came in for moderna booster. According to CDC pt is to receive 0.25ml moderna booster, but instead received the full 0.5ml dose.
Please excuse the black spaces due to this is the second attempt to notify about the adverse effects I had... I needed to provide the lot number to my shot on 6/30/2018 not the first part which was in April of 2018. I had a hard time reading the writing on my paper form so I hope it is correct. All my information was presented in my July/08/2018 report. Thank you.
Pt developed myalgias, chills approx 9 days post vaccination.  Around 11 days post smallpox vaccination, patient developed pruritic macular-papular rash with eventual small (<.5mm) pustules in center of lesions around hair follicles.  Marked take (2.5 cm eschar) apparent though no surrounding cellulitis. Significant tender axillary lymphadenopathy on vaccination side (right arm).  Pt non-toxic, presently feeling well. Patient treated with Zyrtec and motrin with marked improvement in symptoms.
This spontaneous report was received from a registered nurse refers to a 6 month old male patient. On 27-OCT-2014, the patient was vaccinated with a dose of improperly stored ROTATEQ (lot # K001716, expiry date 25-FEB-2016) oral. The outcome of the event was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
Pt reported injection site swelling on day 1 and day 2, loss of taste on day 3, chills on day 4, nausea on day 6 resulting in ED visit and subsequent hospitalization for DKA and NSTEMI Narrative:  Pt received first dose of Moderna COVID vaccine on 1/22/2021. Reported injection site swelling on 1/22 and 1/23. Loss of taste on 1/24. Chills on 1/25. Nausea on 1/25 and 1/26 with decreased oral intake, inability to take diabetes medications. Went to ED on1/27 and was subsequently hospitalized for DKA and NSTEMI for approx 4 days at community hospital (treatment course and medications not available at time of event reporting). Pt was discharged home after about 4 day hospital stay.
she felt stinging; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer or non-health care professional (patient) of unspecified age received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number& Expiry date not reported) via unspecified route of administration on 02Feb2021 as 1st dose, single for COVID-19 Immunization. Patient medical history and concomitant medications were not reported. Patient received the first dose on 02Feb201 and said while they're injecting the vaccine, she felt stinging. Caller asked if it was normal since her friend did not experienced it. The outcome of event was unknown.  Information on the lot/batch number has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Pneumococcal Polysaccharide 23-Valent ,and later that night I started running a fever of 102.2 then got a rash 11/20/2020 Dermatologist said Eczema
When patient came in for her second dose of the 2 dose series, she reported that the first dose not only made her arm sore, but that the soreness extended to her back and then on up to and around her ear.  She asked that I report this as the ear portion was a very "odd" place to feel pain from a shot.
Patient was given the full vial, containing 3 doses, diluted. No adverse reaction noted. Unable to make contact with parent at this time.
Redness, heat, and tenderneas at injection site for 6 days, loss of voice, head ache, fatigue
Received Boostrix IM on 1/31 and within 48 hours developed allergic skin reactions around eyes, face and forehead with redness, swelling, itching and petechial rash. Plus ears were erythematous, plus body pruritic. Pt was sent to dermatologist for treatment.
I've known at least 3 people who had stroke; The initial case was missing the following minimum criteria: [Identifiable reporter]. Upon receipt of the follow-up information on (05Apr2023), this case now contains all required information to be considered valid.  This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CEREBROVASCULAR ACCIDENT (medically significant), outcome "unknown", described as "I've known at least 3 people who had stroke".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Follow-up (05Apr2023) : This is a spontaneous follow up report received from same non-contactable Consumer.  Updated information included: Case upgraded to valid. Patient gender removed as per query response received.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300062721 Same reporter, same product, same event, different patient;US-PFIZER INC-202300145036 Same reporter, same product, same event, different patient;
over her waist, down the back of her legs, inside her left arm; rash with spots which were dime and nickel size and some small spots; sore; muscles felt super tight; felt really sick; headache; fever; shaking like crazy with her bed shaking.; nausea; This case was reported by a consumer via call center representative and described the occurrence of sickness in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included adalimumab (Humira).   On 2nd October 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 3rd October 2020, 1 days after receiving Shingrix, the patient experienced pain and muscle tightness. On 5th October 2020, the patient experienced rash and spot-like rash. In October 2020, the patient experienced sickness, headache, fever, tremor and nausea. On an unknown date, the outcome of the sickness, headache, fever, tremor, nausea, pain and muscle tightness were recovered/resolved and the outcome of the rash and spot-like rash were not recovered/not resolved.   It was unknown if the reporter considered the sickness, headache, fever, tremor, nausea, pain and muscle tightness to be related to Shingrix. The reporter considered the rash and spot-like rash to be possibly related to Shingrix.  Additional details were provided as follows: The patient was vaccinated with Shingrix and 3 days after vaccination patient had broke out in a rash with spots which were dime and nickel size and some small spots as well.  The rash was all over her waist, down the back of her legs, inside her left arm. The patient was visited a dermatologist and they could not determine the cause of the rash.   They biopsied the rash and it came back inconclusive but it may be a possible reaction to a medication. The patient was also taking Humira. The patient felt really sick the night after receiving the vaccination with a headache, fever, nausea and she was shaking like crazy with her bed shaking and more she tried to stop the shaking the worse it got. The patient was sore the next day and her muscles felt super tight. Till the time of reporting rash was unresolved while other symptoms were resolved. The patient stated that she experienced all the side effects listed for the Shingrix vaccine. The reporter consent to follow up.
I started to have very painful knees, I went to my Ortho dovtor and am getting injections to see if this helps.  I have NEVER had such pain and problems before.  it is hard to go up or down steps and I wear a brace on both legs.  I will never get a booster that is for sure.
On 04/16/04 mother called to report child temp of 102.0.  2-3 red "itchy" spots to face and on chest area. Varicella vaccine administered on 04/05/04.  Advised mother to take child to pediatrician ASAP for assessment.   On 4/19/04 spoke with mother.  Pediatrician diagnosed chickenpox.  Comfort measures advised for itching.
The patient presented with chest pain and dyspnea on exertion  which started the day after receiving the second dose of the Moderna Covid vaccine.   Pt was found to have myocarditis.  He was admitted to the hospital and treated with NSAIDS and Steroids.  He improved and was discharged after 2 days.
Very sore arm day of shot (took Advil, which helped), migraine at night, mild nausea, sleeplessness, migraine next morning, some nausea very tired next day; sluggish feeling
1228 Vaccines given by 2 nurses at same time. 1229 client started to stare off into space then slumped into chair. Assisted by staff to floor, 1230 water given and cool cloth applied to back of neck, color pale and was answering questions appropriate. C/o being hot fanned by staff. 1232 Client assisted to chair. 1235 Client ambulated with assist to chair in waiting area. Father stated client in hospital 2 weeks prior with viral infection r/o meningitis. 1240 Client decreased facial color B/P 92/60.
Case number PHEH2014US020573, is an initial spontaneous report from a nurse received on 10 OCT 2014. This report refers to a 20-year-old-female. Past medical history and concomitant medications were not reported. On 10 OCT 2014, the patient was vaccinated with 0.5 ml of FLUVIRIN 2014/2015 (batch number: 1412121) intramuscularly. It was reported that the patient received FLUVIRIN from open multiple dose vial (MDV) that reached 72 F overnight. No adverse event was reported following this medication error (incorrect storage of drug).
PT RETURNED TO CLINIC ON 02/27/2018 WITH COMPLAINTS OF SWELLING AND PAIN IN LEFT ARM. PT HAS A SMALL CIRCLE AROUND APPROXIMATE INJECTION SITE, WARM TO TOUCH.  PT STATES IT IS PAINFUL AND UNABLE TO LAY ON THAT SIDE AT NIGHT. SYMPTOMS STARTED 2-3 DAYS BEFORE RETURNING BACK TO CLINIC. PT DENIES ANY INJURIES TO THE ARM OR ANY OTHER VACCINES. PT HAS NOT SEEN AN MD. REFERRED HER TO THE PMC CLINIC OR THE AFTER HOURS CLINIC.
I got my first dose of the Pfizer shot around 4 pm and after midnight I felt a pinching in my chest which did not go away. Around 10 am I went to urgent care and was having trouble breathing (possibly a panic attack) and the chest pain is still there. They did an EKG which looked normal so I left there feeling better mentally but not feeling better from the chest pain.
This spontaneous report as received from a certified nursing assistant refers to multiple patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were inadvertently vaccinated with improperly stored GARDASIL (strength, dose, route and site of administration, lot # and expiry date were not reported). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Pt c/o stuffy nose, and productive cough, also left sided sore throat.  This shot was second in series of three Twinrix injections.  Pt states she had the same symptoms following the first injection given on 10/03/2011.  She was given CXR by pmd and pneumonia was ruled out.  Tx'd with Cipro for 10 days, Claritin B and Flonase.
I believe the Pfizer vaccine got me and my 12 year old daughter sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 12 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "I believe the Pfizer vaccine got me and my 12 year old daughter sick".  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
migraine from sinuses; migraine from sinuses; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a 39-year-old female patient received BNT162B2, via an unspecified route of administration on 16Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications was not reported. It was reported that the patient got the vaccine on 16Jan2021, and she experienced migraine from sinuses. She asked if it is okay to take Migraine medicine while she had her vaccine. The outcome of the events was unknown.  Information about Lot/Batch number is requested.
Loss of balance causing a fall.  Fatigue.  Meclizine, PT.
This spontaneous report as received from a pharmacist refers to a 71 years old female patient. On 18-JUN-2014 the patient was vaccinated with ZOSTAVAX (vial, 19400 PFU, LOT#: J013135, expiry date: 17-JAN-2016, dose, frequency were not reported). On unknown date in June 2014 the patient experienced injection site pain and pruritus. It was reported that the patient contacted the pharmacist. No treatment was given for adverse event. The outcome of the injection site pain and pruritus was reported as not recovered/not resolved. The causality between ZOSTAVAX and injection site pain and pruritus was not reported. Additional information has been requested.